Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic polymorphisms of xeroderma pigmentosum group D gene Asp312Asn and Lys751Gln and susceptibility to prostate cancer: a systematic review and meta-analysis.

Gene - 10 Nov 2013

Ma Qingtong, Qi Can, Tie Chong, Guo Zhanjun

Abstract excerpt

Many studies have reported the role of xeroderma pigmentosum group D (XPD) with prostate cancer risk, but the results remained controversial. To derive a more precise estimation of the relationship, a meta-analysis was performed. Odds ratios (ORs) with 95% confidence intervals (CIs) were estimate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Amino Acid Substitution
Share to Asian People
Share to Black People

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Models, Genetic

Share to Odds Ratio

Share to Prostatic Neoplasms

Share to White People

Share to Xeroderma Pigmentosum Group D Protein

Source

Identifiers

PMID: 23973729
DOI: 10.1016/j.gene.2013.08.053

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-23973729-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic polymorphisms of xeroderma pigmentosum group D gene Asp312Asn and Lys751Gln and susceptibility to prostate cancer: a systematic review and meta-analysis.PMID 23973729Read ↗

XPD Asp312Asn polymorphism is a risk factor for prostate cancer.Semantic proximity Read ↗

Genetic polymorphisms of xeroderma pigmentosum group D and prostate cancer risk: a meta-analysis.Semantic proximity Read ↗

Impact of two common xeroderma pigmentosum group D (XPD) gene polymorphisms on risk of prostate cancer.Semantic proximity Read ↗

Xeroderma pigmentosum complementation group D (XPD) gene polymorphisms contribute to bladder cancer risk: a meta-analysis.Semantic proximity Read ↗

Polymorphisms in XPD and hOGG1 and prostate cancer risk: a meta-analysis.Semantic proximity Read ↗

Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.Semantic proximity Read ↗

Association between XPD Lys751Gln polymorphism and bladder cancer susceptibility: an updated and cumulative meta-analysis based on 6,836 cases and 8,251 controls.Semantic proximity Read ↗

XPD Asp312Asn and Lys751Gln polymorphisms and breast cancer susceptibility: a meta-analysis.Semantic proximity Read ↗

XPD Lys(751)Gln and Asp (312)Asn polymorphisms and bladder cancer risk: a meta-analysis.Semantic proximity Read ↗

The association between XPC Lys939Gln gene polymorphism and urinary bladder cancer susceptibility: a systematic review and meta-analysis.Semantic proximity Read ↗

Association between the XPD/ERCC2 Lys751Gln polymorphism and risk of cancer: evidence from 224 case-control studies.Semantic proximity Read ↗

Effects of Xeroderma pigmentosum group C polymorphism on the likelihood of prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.